Literature DB >> 7104148

Effect of pindolol and propranolol on renal function of patients with hypertension.

A Pasternack, P Pörsti, L Pöyhönen.   

Abstract

1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study. 2 Pindolol caused a smaller decrease in plasma renin activity and heart rate than propranolol. 3 Glomerular filtration rate and effective renal plasma flow remained unchanged during therapy with either agent.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7104148      PMCID： PMC1402144          DOI： 10.1111/j.1365-2125.1982.tb01921.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  12 in total

1.  Glomerular filtration rate and renal plasma flow in patients with essential hypertension before and after treatment with alprenolol.

Authors:  E B Pedersen
Journal:  Acta Med Scand       Date:  1975-11

2.  Blood pressure and renin during treatment with pindolol.

Authors:  F Fyhrquist; K Kurppa; M Huuskonen; A Koistinen
Journal:  Acta Med Scand       Date:  1977

3.  Radioimmunoassay of plasma renin activity.

Authors:  F Fyhrquist; P Soveri; L Puutula; U H Stenman
Journal:  Clin Chem       Date:  1976-02       Impact factor: 8.327

4.  Propranolol therapy in essential hypertension.

Authors:  H Lydtin; T Kusus; W Daniel; W Schierl; M Ackenheil; H Kempter; G Lohmöller; M Niklas; I Walter
Journal:  Am Heart J       Date:  1972-05       Impact factor: 4.749

5.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.

Authors:  H Ibsen; P Sederberg-Olsen
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

6.  Mechanism of increased sodium reabsorption during propranolol administration.

Authors:  A S Nies; J S McNeil; R W Schrier
Journal:  Circulation       Date:  1971-10       Impact factor: 29.690

7.  [Comparative study of the influence of beta-adrenergic stimulants and adrenergic blocking drugs on renal function in normal humans].

Authors:  G Bufano; L Piacentini
Journal:  Minerva Med       Date:  1969-04-04       Impact factor: 4.806

8.  Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension.

Authors:  F Alhenc-Gelas; P F Plouin; M B Ducrocq; P Corvol; J Menard
Journal:  Am J Med       Date:  1978-06       Impact factor: 4.965

9.  [Determination of 131-iodo-ortho-iodohippuric acid total clearance as a basis for quantitative radionephrography].

Authors:  H Rösler
Journal:  Dtsch Med Wochenschr       Date:  1967-05-12       Impact factor: 0.628

10.  [Beta-receptors and renal hemodynamics in humans].

Authors:  J Schirmeister; M Decot; W Hallauer; H Willmann
Journal:  Arzneimittelforschung       Date:  1966-07
View more
  4 in total

Review 1.  Influence of antihypertensive therapy on renal function.

Authors:  U Frei; R Schindler; K M Koch
Journal:  Clin Investig       Date:  1992

2.  A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.

Authors:  D G Waller; J Mihindukulasuriya; D J Warren
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

3.  Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.

Authors:  I G Mackay; A M Macnicol; H J Smith; A D Cumming; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

4.  Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.

Authors:  A S Gross; A J McLachlan; I Minns; J B Beal; S E Tett
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.